End‐stage renal disease – not an equal opportunity disease: the role of genetic polymorphisms

Abstract excerpt

Despite several decades of development in renal replacement therapy, end-stage renal disease (ESRD) patients continue to have markedly increased morbidity and mortality especially caused by cardiovascular disease (CVD). This shows that current strategies, e.g. the focus on dialysis adequacy, to improve the clinical outcome in ESRD patients have to be complemented by novel approaches. Although traditional risk...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chronic Kidney Disease and Diabetes
• Share to Dialysis and Renal Disease Management
• Share to Renal Diseases and Glomerulopathies